AR

Argentina

4742 clinical trials

Find Trials

Clinical Trials (4742)

Showing 20 of 4,742 trialsScroll for more
NCT05296798Phase 37 sites

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Active Not Recruiting
NCT06456346Phase 34 sites

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Recruiting
NCT07533175Phase 34 sites

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Not Yet Recruiting
NCT06632444Phase 311 sites

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Recruiting
NCT07064759Phase 36 sites

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting
NCT06684847Phase 313 sites

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Active Not Recruiting
NCT05352919Phase 316 sites

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Enrolling By Invitation

Prospective International Multi-center Clinical Trial of PGT-A Upgrade

Not Yet Recruiting
NCT06629779Phase 38 sites

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Recruiting
NCT06717347Phase 38 sites

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Recruiting
NCT06152575Phase 34 sites

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Recruiting
NCT05166889Phase 311 sites

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Completed
NCT06676319Phase 216 sites

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Recruiting
NCT06846671Phase 33 sites

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Recruiting
NCT06672237Phase 33 sites

A Phase 3 Study of NTLA-2001 in ATTRv-PN

Recruiting
NCT06824467Phase 36 sites

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Recruiting
NCT06291376Phase 36 sites

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
NCT05450692Phase 35 sites

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Active Not Recruiting
NCT06331312Phase 32 sites

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

Active Not Recruiting
NCT07284849Phase 311 sites

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Recruiting